Resolution of Notice of Concern (NOC)
IS
A-31 Clinical Unit I at Accutest Research Laboratories (I) Pvt. Ltd has addressed the concerns highlighted in the Notice of Concern (NOC) by the WHO.
PQT/MED publishes first invitation to manufacturers of medicinal products for treatment of disorders caused by use of tobacco, to submit an Expression of Interest (EOI)
M
A first invitation to manufacturers of medicinal products for treatment of disorders caused by use of tobacco, to submit an Expression of Interest (EOI) for product evaluation
First oral zinc solution prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First long-acting insulin analogues prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
1st Invitation to manufacturers of medicinal products for treatment of multi-drug resistant bacterial infections, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
A 1st Invitation for Expression of Interest (EOI) for treatment of multi-drug resistant bacterial infections has been published by the WHO Prequalification Unit - Medicines Assessment Team (PQT/MED
ICH Harmonised Guideline M10 Bioanalytical Method Validation and Study Sample Analysis to be implemented by PQT/MED
M
The recent ICH Harmonised Guideline M10 Bioanalytical Method Validation and Study Sample Analysis, adopted by ICH 24 May 2022, will be implemented by PQT/MED effective 1 May 2023
Request for Proposals (RFP) - WHO Prequalification website maintenance and support
ID
IVD
IS
M
V
VCP
The purpose of this Request for Proposals (RFP) is to enter into a contractual agreement with a successful bidder and select a suitable contractor to carry out the maintenance and support of the ev
First human insulins prequalified
M
The first human insulins have been prequalified by WHO: fast-acting human insulin 100 IU/ml and intermediate-acting human insulin 100 IU/ml from Novo Nordisk A/S.